Brought to you by 
Iconic brings in $4.2mm via third round
25 Apr 2014
Executive Summary
According to industry sources, Iconic Therapeutics (oncology and ophthalmic therapies) has closed the first tranche of its third financing round, bringing in $4.2mm from Elm Street Ventures, the ATDC Seed Capital Fund, and angels.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Iconic brings in $4.2mm via third round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice